Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease.


Journal

Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 15 07 2019
accepted: 01 10 2019
pubmed: 9 10 2019
medline: 4 6 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

Serotoninergic system is one of the most important neurotransmission systems investigated in the field of psychiatry. Extensive evidence reveals how alterations of this system, and especially of the SLC6A4 gene, may be associated with psychiatric disorders. In this study we aimed to evaluate the pleiotropic nature of SLC6A4 alterations and their association with the overall risk of brain diseases rather than disorder-specific. SLC6A4 variants, namely 5HTTLPR, STin2, rs2066713, rs25531, rs4251417, rs6354 and rs7224199 were investigated in 4 independent cohorts of subjects with specific psychiatric disorders, including Alcohol dependence disorder (ALC), Alzheimer disease (ALZ), Schizophrenia (SCZ) and Bipolar disorder (BPD). Other variables (biochemical parameters and Psychiatric scales scores) were also tested for association. SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p

Identifiants

pubmed: 31595439
doi: 10.1007/s11033-019-05119-5
pii: 10.1007/s11033-019-05119-5
doi:

Substances chimiques

SLC6A4 protein, human 0
Serotonin Plasma Membrane Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-200

Commentaires et corrections

Type : ErratumIn

Références

Dement Geriatr Cogn Disord. 2005;19(2-3):97-105
pubmed: 15591799
Front Behav Neurosci. 2014 May 20;8:189
pubmed: 24904340
Hum Genet. 2014 Jul;133(7):905-18
pubmed: 24590108
Alcohol Alcohol. 2016 Mar;51(2):164-71
pubmed: 26311211
Mol Psychiatry. 2006 Mar;11(3):224-6
pubmed: 16402131
World J Biol Psychiatry. 2011 Mar;12(2):134-42
pubmed: 20642399
J Alzheimers Dis. 2009;18(1):125-30
pubmed: 19625753
Int Clin Psychopharmacol. 2016 Jan;31(1):1-7
pubmed: 26544898
Pharmgenomics Pers Med. 2012;5:19-35
pubmed: 23226060
Gene. 2017 Mar 1;603:34-41
pubmed: 27964944
Br J Psychiatry. 1986 Dec;149:698-709
pubmed: 3790869
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Med Sci (Paris). 2004 Dec;20(12):1132-8
pubmed: 15581469
Science. 1996 Nov 29;274(5292):1527-31
pubmed: 8929413
Eur Neuropsychopharmacol. 2012 Apr;22(4):239-58
pubmed: 22137564
Transl Psychiatry. 2011 Aug 30;1:e37
pubmed: 22832611
Psychiatr Genet. 2013 Oct;23(5):222-3
pubmed: 23969989
Biol Psychiatry. 1988 Feb 1;23(3):271-84
pubmed: 3337862
J Affect Disord. 2001 Sep;66(1):1-11
pubmed: 11532527
Am J Med Genet. 2000 Feb 7;96(1):36-42
pubmed: 10686549
Br J Psychiatry. 2001 Apr;178:352-9
pubmed: 11282815
Acta Neuropsychiatr. 2008 Jun;20(3):139-44
pubmed: 25385523
Int J Environ Res Public Health. 2009 Jul;6(7):1980-90
pubmed: 19742166
Curr Pharm Des. 2016;22(8):949-54
pubmed: 26654774
Am J Geriatr Psychiatry. 2014 Nov;22(11):1140-8
pubmed: 23973251
J Alzheimers Dis. 2009;16(1):181-7
pubmed: 19158434
PLoS One. 2014 Mar 03;9(3):e88031
pubmed: 24595335
J Clin Psychiatry. 1992 Oct;53 Suppl:46-51
pubmed: 1385390
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):163-73
pubmed: 18957375
Adv Pharmacol. 2013;68:167-97
pubmed: 24054145
Behav Sci Law. 2000;18(5):581-604
pubmed: 11113963
Am J Psychiatry. 2002 Jan;159(1):23-9
pubmed: 11772685
Psychiatr Genet. 2015 Apr;25(2):47-58
pubmed: 25710844
PLoS One. 2015 Mar 16;10(3):e0119743
pubmed: 25775400
Ann N Y Acad Sci. 1996 Mar 22;780:176-84
pubmed: 8602731
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
Dement Geriatr Cogn Disord. 2016;41(5-6):334-47
pubmed: 27414430
Biol Psychiatry. 1994 Sep 15;36(6):395-421
pubmed: 7803601
Ann N Y Acad Sci. 1990;600:405-15; discussion 415-7
pubmed: 1701291
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15251-5
pubmed: 10611371
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
J Stud Alcohol Drugs. 2011 Sep;72(5):752-62
pubmed: 21906503
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Trends Cogn Sci. 2011 Sep;15(9):401-8
pubmed: 21835681

Auteurs

Marco Calabrò (M)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Laura Mandelli (L)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Viale Carlo Pepoli 5, 40123, Bologna, Italy.

Concetta Crisafulli (C)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Stefano Porcelli (S)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Viale Carlo Pepoli 5, 40123, Bologna, Italy.

Diego Albani (D)

Laboratory of Biology of Neurodegenerative Disorders, Neuroscience Department, Istituto di Ricerche Farmacologiche Mario Negri IRCSS, Milan, Italy.

Antonis Politis (A)

Department of Psychiatry, University of Athens Medical School, Eginition Hospital, Athens, Greece.

George N Papadimitriou (GN)

Department of Psychiatry, University of Athens Medical School, Eginition Hospital, Athens, Greece.

Marco Di Nicola (M)

Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Luigi Janiri (L)

Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Roberto Colombo (R)

Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Giovanni Martinotti (G)

Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti, Chieti, Italy.

Antonello Bellomo (A)

Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.

Eduard Vieta (E)

Bipolar Disorders Unit, Institute of Neuroscience, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.

Stefano Bonassi (S)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Rome, Italy, and Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy.

Alessandra Frustaci (A)

Barnet, Enfield and Haringey Mental Health NHS Trust, St.Ann's Hospital, St.Ann's Road, London, N15 3 TH, UK.

Giuseppe Ducci (G)

Mental Health Department, ASL Roma 1, Rome, Italy.

Stefano Landi (S)

Dipartimento di Biologia, Università di Pisa, Pisa, Italy.

Stefania Boccia (S)

Section of Hygiene, Institute of Public Health, Universita' Cattolica del Sacro Cuore, Fondazione Policlinico "Agostino Gemelli" IRCCS, Rome, Italy.

Alessandro Serretti (A)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Viale Carlo Pepoli 5, 40123, Bologna, Italy. alessandro.serretti@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH